Literature DB >> 19188789

Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease.

Raksha Urs1, Elizabeth Potter, Warren Barker, Jason Appel, David A Loewenstein, Weizhao Zhao, Ranjan Duara.   

Abstract

OBJECTIVE: Subjects with mild cognitive impairment (MCI) and mild Alzheimer disease (AD) can be distinguished from elderly subjects with no cognitive impairment (NCI) by the degree of atrophy in the entorhinal cortex (ERC) and the hippocampus (HPC), quantified by volumetric magnetic resonance image (MRI) studies. Because volumetric MRI requires rigorous standards for image acquisition and analysis and is not suitable for routine clinical use, we have used calibrated visual rating to measure atrophy in the ERC, HPC, and perirhinal cortex (PRC) and evaluated its utility in the diagnosis of very early AD.
METHODS: Thus far, visual rating methods, which have been found to be reliable and sensitive only for measurement of atrophy of the HPC or for the entire medial temporal region, have been found to be relatively insensitive for discriminating mild AD from elderly NCI subjects. We have developed a computer-based visual rating system (VRS) using reference images for calibration of atrophy ratings in several discrete brain regions, including the ERC, HPC, and PRC. The VRS reference images facilitate training of raters and promote standardization of all atrophy ratings. Interrater and intrarater reliability measurements were assessed; subsequently, the ability of VRS to discriminate the diagnoses among 73 elderly subjects was studied (NCI = 27, MCI = 23, and AD = 23).
RESULTS: Kappa values for interrater reliability of the ERC, HPC, and PRC were between 0.75 and 0.94, and for intrarater reliability, they were between 0.84 and 0.93, indicating that VRS enables highly reliable ratings to be obtained. Atrophy ratings in the ERC, HPC, and PRC distinguished AD from NCI subjects but did not distinguish AD from MCI subjects who tended to have intermediate levels of atrophy. Right and left ERC ratings and the right HPC rating distinguished MCI from NCI subjects.
CONCLUSIONS: The visual rating system is the first semiquantitative method that enables reliable measurements of ERC atrophy, and ERC measurement was found to be the best discriminator between MCI and NCI subjects. Visual rating system is a user-friendly tool that can allow a radiologist or a clinician to use structural MRI scans to be used as a biomarker in the diagnosis of prodromal AD.

Entities:  

Mesh:

Year:  2009        PMID: 19188789     DOI: 10.1097/RCT.0b013e31816373d8

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  19 in total

1.  Minimal atrophy of the entorhinal cortex and hippocampus: progression of cognitive impairment.

Authors:  Daniel Varon; David A Loewenstein; Elizabeth Potter; Maria T Greig; Joscelyn Agron; Qian Shen; Weizhao Zhao; Maria Celeste Ramirez; Isael Santos; Warren Barker; Huntington Potter; Ranjan Duara
Journal:  Dement Geriatr Cogn Disord       Date:  2011-04-13       Impact factor: 2.959

2.  Diagnosis and staging of mild cognitive impairment, using a modification of the clinical dementia rating scale: the mCDR.

Authors:  Ranjan Duara; David A Loewenstein; Maria T Greig-Custo; Ashok Raj; Warren Barker; Elizabeth Potter; Elizabeth Schofield; Brent Small; John Schinka; Yougui Wu; Huntington Potter
Journal:  Int J Geriatr Psychiatry       Date:  2010-03       Impact factor: 3.485

3.  Cross-validation of brain structural biomarkers and cognitive aging in a community-based study.

Authors:  James T Becker; Ranjan Duara; Ching-Wen Lee; Leonid Teverovsky; Beth E Snitz; Chung-Chou H Chang; Mary Ganguli
Journal:  Int Psychogeriatr       Date:  2012-03-16       Impact factor: 3.878

4.  Correlation between volume and morphological changes in the hippocampal formation in Alzheimer's disease: rounding of the outline of the hippocampal body on coronal MR images.

Authors:  Michito Adachi; Shinobu Kawakatsu; Takamichi Sato; Fumi Ohshima
Journal:  Neuroradiology       Date:  2012-02-16       Impact factor: 2.804

5.  A clinically-translatable machine learning algorithm for the prediction of Alzheimer's disease conversion: further evidence of its accuracy via a transfer learning approach.

Authors:  Massimiliano Grassi; David A Loewenstein; Daniela Caldirola; Koen Schruers; Ranjan Duara; Giampaolo Perna
Journal:  Int Psychogeriatr       Date:  2018-11-14       Impact factor: 3.878

Review 6.  Humanin and the receptors for humanin.

Authors:  Masaaki Matsuoka; Yuichi Hashimoto
Journal:  Mol Neurobiol       Date:  2009-12-09       Impact factor: 5.590

7.  Multimodality Imaging of Dementia: Clinical Importance and Role of Integrated Anatomic and Molecular Imaging.

Authors:  Kunal P Patel; David T Wymer; Vinay K Bhatia; Ranjan Duara; Chetan D Rajadhyaksha
Journal:  Radiographics       Date:  2020 Jan-Feb       Impact factor: 5.333

8.  Test-retest stability of calibrated BOLD-fMRI in HIV- and HIV+ subjects.

Authors:  Beau Ances; Florin Vaida; Ronald Ellis; Richard Buxton
Journal:  Neuroimage       Date:  2010-10-13       Impact factor: 6.556

9.  Who wants a free brain scan? Assessing and correcting for recruitment biases in a population-based sMRI pilot study.

Authors:  Mary Ganguli; Ching-Wen Lee; Tiffany Hughes; Beth E Snitz; Jennifer Jakubcak; Ranjan Duara; Chung-Chou H Chang
Journal:  Brain Imaging Behav       Date:  2015-06       Impact factor: 3.978

10.  The cognitive change checklist (3CL): cross-validation of a measure of change in everyday cognition.

Authors:  John A Schinka; Ashok Raj; David A Loewenstein; Brent J Small; Ranjan Duara; Huntington Potter
Journal:  Int J Geriatr Psychiatry       Date:  2010-03       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.